Search

Your search keyword '"Scherillo, I."' showing total 10 results
Start Over Author "Scherillo, I."
10 results on '"Scherillo, I."'

4. Aliment…..azione e Salute

Author

TRIASSI, MARIA, FABBROCINI, GABRIELLA, MONTUORI, PAOLO, AYALA, FABIO, RUSSO I, PAGANO A, MAINADI P, SCHERILLO I, VAIRANO MP, TROIANO E, RESCIGNO O, RUSSO O, Triassi, Maria, Fabbrocini, Gabriella, Montuori, Paolo, Russo, I, Pagano, A, Mainadi, P, Scherillo, I, Vairano, Mp, Troiano, E, Rescigno, O, Russo, O, and Ayala, Fabio

Subjects
Salute, Alimentazione
Abstract

Descrive le modalità di prevenzione delle malattie associate all'alimentazione

Published
2005

7. Human papilloma virus (HPV), cervical cancer incidence and screening uptake: Differences among northern, central and southern Italy,Epidemiologia del papilloma virus umano (HPV), incidenza del cancro della cervice uterina e diffusione dello screening: differenze fra macroaree in Italia

Author

Rossi, P. G., Chini, F., Borgia, P., Guasticchi, G., Carozzi, F. M., Confortini, M., Angeloni, C., Buzzoni, C., Buonaguro, F. M., Lattanzi, A., Maccallini, V., Caraceni, D., Fortunato, C., Macis, R., Pilia, M., Caredda, V., Carillo, G., Di Iasi, A., Santarsiere, A., Casto, L., Manno, M., Santangelo, C., Pini, M. T., Gallicchio, G., Scherillo, I., Barretta, E., Santis, V., Ercole, F., Scalisi, A., Spampinato, P., Cantarella, M. A., Miano, M. G., Capparucci, P., Marsili, L. M., Tufi, M. C., Gomez, V., Verrico, G., Schiboni, M. L., Pellegrini, A., Bove, E., D’addetta, A., Placidi, A., Tornesello, M. L., Loquercio, G., Losito, S., Botti, G., Vecchione, A., Bisanzi, S., Sani, C., Venturini, G., Irene Paganini, Tinacci, G., and Federici, A.

8. Diagnostic and infection control strategies for Clostridioides difficile infections in a setting of high antimicrobial resistance prevalence

Author

Bertolino, L., Patauner, F., Gagliardi, M., D’amico, F., Crivaro, V., Bernardo, M., Scherillo, I., Bellitti, F., Cusano, C., Greco, R., Panetta, V., Durante, A., Di Caterino, A., Frieri, A., Cioffi, G., Nappo, M., Corrado, M., Lanzieri, M., Sabatini, P., Bettelli, R., Russo, R. D., Taddeo, M. L., Petrone, R., Di Sevo, M. G., Iannuzzo, M., Iervolino, M., Buonocore, R., D’agostino, F., Gambardella, M., Martino, A., Spagnuolo, S., Savarese, M., Sole, S., Russo, C., Agozzino, E., Galdiero, M., Martino, R., Calemma, R., Sciambra, A., Aprea, C., Colaccio, D., Di Guida, P., Venditti, M., emma montella, Guerriero, F., Perrotta, R., Di Filippo, U., Pizza, A., Di Fronzo, A., Lombardi, A., Capuano, L., Stefano, A., Mastropietro, A., Mastro, M., Loffreda, R., Maccarone, L., Di Tora, A., Oto, S., Tammaro, C., Mondelli, A. C., Ruocco, M., Ferraro, B., Petrosino, A., Presta, S. S. A., Mangoni, E. D., Bertolino, Lorenzo, Patauner, Fabian, Gagliardi, Massimo, D'Amico, Fabiana, Crivaro, Valeria, Bernardo, Mariano, Scherillo, Isabella, Bellitti, Filomena, Cusano, Caterina, Greco, Rita, Panetta, Vittorio, Durante, Adriana, Di Caterino, Alfonsina, Frieri, Angelo, Cioffi, Grazia, Nappo, Maria, Corrado, Mariano, Lanzieri, Michele, Sabatini, Paola, Bettelli, Roberto, Dello Russo, Rita, Taddeo, Maria Luisa, Petrone, Rosalba, Di Sevo, Maria Giovanna, Iannuzzo, Mariateresa, Iervolino, Mario, Buonocore, Raffaella, D'Agostino, Federica, Gambardella, Michele, De Martino, Antonio, Spagnuolo, Silvano, Savarese, Marina, Sole, Sabina, Russo, Carmela, Agozzino, Erminia, Galdiero, Massimiliano, Martino, Rosa, Calemma, Rosa, Sciambra, Antonio, Aprea, Cristina, Colaccio, Diego, Di Guida, Pasquale, Venditti, Michele, Montella, Emma, Guerriero, Francesco, Perrotta, Rita, Di Filippo, Umberto, Pizza, Angelo, Di Fronzo, Antonietta, Lombardi, Anna, Capuano, Luigi, De Stefano, Andrea, Mastropietro, Angela, Mastro, Matilde, Loffreda, Romolo, Maccarone, Luigi, Di Tora, Amelia, Oto, Savino, Tammaro, Carminantonio, Mondelli, Antonio Claudio, Ruocco, Maria, Ferraro, Biagio, Petrosino, Alfonso, Presta, Silvia S A, and Durante Mangoni, Emanuele

Subjects
Hospitalization, Cross Infection, Infection Control, Clostridioides, Italy, Clostridioides difficile, Incidence, Drug Resistance, Bacterial, Clostridium Infections, Prevalence, Humans, Prospective Studies, Anti-Bacterial Agents
Abstract

Clostridioides difficile (CD) is a major nosocomial pathogen and the leading cause of antibiotic-associated diarrhoea. In light of the strong association between antimicrobial use and CD infections (CDI), it may be hypothesised that areas at higher prevalence of antimicrobial resistance, like the region of Campania in southern Italy, could also have a higher rate of CDI. In this multicentre, region-based, prospective study, we analysed such issues, exploiting CDI incidence data collected from local hospitals. In 2016, the Italian National Centre for Disease Control supported a project involving three Italian regions: Friuli Venezia Giulia, Lazio and Campania. In Campania, a network of 49 hospitals willing to participate in the project was created. The project consisted of two phases: a survey on practice patterns concerning CDI and an epidemiological surveillance study. We identified a stringent need to improve awareness about CDI among the regional health-care community, as a widespread lack of surveillance programmes for CDI control was observed (existing in only 40% of participating facilities). Moreover, almost half of the participating hospitals (n=16, 43%) had no standardised procedures or protocols to control and prevent CDI. In the second phase of the study, we collected data of CDI cases during a six-month surveillance programme. In all, 87 CDI cases were observed, for a total of 903,334 patient bed-days and 122,988 admissions. According to the above data, CDI incidence was 0.96 cases/10000 patient bed-days, much lower than expected based on prior studies conducted elsewhere. The results of our study suggest CDI remains a rather neglected clinical issue in Campania. Despite a high burden of antimicrobial resistance and antimicrobial use in our geographic setting, we observed a very low incidence of CDI. Such a low incidence could be explained by underdiagnosis, but could also be related to actual diet, the lower patient age or the specific genetic background. However, further studies are warranted to either confirm or rebut the above hypotheses.

9. Diagnostic and infection control strategies for Clostridioides difficile infections in a setting of high antimicrobial resistance prevalence.

Author

Bertolino L, Patauner F, Gagliardi M, D'Amico F, Crivaro V, Bernardo M, Scherillo I, Bellitti F, Cusano C, Greco R, Panetta V, Durante A, Di Caterino A, Frieri A, Cioffi G, Nappo M, Corrado M, Lanzieri M, Sabatini P, Bettelli R, Dello Russo R, Taddeo ML, Petrone R, Di Sevo MG, Iannuzzo M, Iervolino M, Buonocore R, D'Agostino F, Gambardella M, De Martino A, Spagnuolo S, Savarese M, Sole S, Russo C, Agozzino E, Galdiero M, Martino R, Calemma R, Sciambra A, Aprea C, Colaccio D, Di Guida P, Venditti M, Montella E, Guerriero F, Perrotta R, Di Filippo U, Pizza A, Di Fronzo A, Lombardi A, Capuano L, De Stefano A, Mastropietro A, Mastro M, Loffreda R, Maccarone L, Di Tora A, Oto S, Tammaro C, Mondelli AC, Ruocco M, Ferraro B, Petrosino A, Presta SSA, and Durante Mangoni E

Subjects
Anti-Bacterial Agents therapeutic use, Clostridioides, Cross Infection, Drug Resistance, Bacterial, Humans, Incidence, Italy, Prevalence, Prospective Studies, Clostridioides difficile, Clostridium Infections prevention & control, Hospitalization, Infection Control
Abstract

Clostridioides difficile (CD) is a major nosocomial pathogen and the leading cause of antibiotic-associated diarrhoea. In light of the strong association between antimicrobial use and CD infections (CDI), it may be hypothesised that areas at higher prevalence of antimicrobial resistance, like the region of Campania in southern Italy, could also have a higher rate of CDI. In this multicentre, region-based, prospective study, we analysed such issues, exploiting CDI incidence data collected from local hospitals. In 2016, the Italian National Centre for Disease Control supported a project involving three Italian regions: Friuli Venezia Giulia, Lazio and Campania. In Campania, a network of 49 hospitals willing to participate in the project was created. The project consisted of two phases: a survey on practice patterns concerning CDI and an epidemiological surveillance study. We identified a stringent need to improve awareness about CDI among the regional health-care community, as a widespread lack of surveillance programmes for CDI control was observed (existing in only 40% of participating facilities). Moreover, almost half of the participating hospitals (n=16, 43%) had no standardised procedures or protocols to control and prevent CDI. In the second phase of the study, we collected data of CDI cases during a six-month surveillance programme. In all, 87 CDI cases were observed, for a total of 903,334 patient bed-days and 122,988 admissions. According to the above data, CDI incidence was 0.96 cases/10000 patient bed-days, much lower than expected based on prior studies conducted elsewhere. The results of our study suggest CDI remains a rather neglected clinical issue in Campania. Despite a high burden of antimicrobial resistance and antimicrobial use in our geographic setting, we observed a very low incidence of CDI. Such a low incidence could be explained by underdiagnosis, but could also be related to actual diet, the lower patient age or the specific genetic background. However, further studies are warranted to either confirm or rebut the above hypotheses.

Published
2021

10. Estimated acceptance of HPV vaccination among Italian women aged 18-26 years.

Author

Giambi C, Donati S, Declich S, Salmaso S, Ciofi Degli Atti ML, Alibrandi MP, Brezzi S, Carozzi F, Collina N, Franchi D, Lattanzi A, Meda M, Minna MC, Nannini R, Scherillo I, and Bella A

Subjects
Adolescent, Adult, Female, Humans, Italy, Young Adult, Papillomavirus Vaccines administration & dosage, Papillomavirus Vaccines immunology, Patient Acceptance of Health Care psychology, Patient Acceptance of Health Care statistics & numerical data, Vaccination psychology
Abstract

In Italy vaccination against human papillomavirus (HPV) was introduced in the national immunization programme in 2007; the primary target for this vaccination is 11-year-old females, whereas vaccination for older age groups is still a matter of debate. This project was carried out in the period 2007-2009 to estimate the acceptance rate among 18-26-year-old, to whom free-of-charge vaccination was actively offered. Socio-demographic factors associated with acceptance were also investigated. A sample of 1159 women was randomly selected from resident population lists of 10 Local Health Units in 6 of Italy's 21 Regions; 1032 women were deemed eligible for the study. Of the eligible women, 580 received at least one vaccine dose for an acceptance rate of 56.2% and 542 received all three vaccine doses (52.6%). The acceptance rate was significantly higher for: residents of northern and central Italy (OR(adj)=2.22, 95%CI 1.64-3.01 and OR(adj)=1.77, 95%CI, 1.20-2.61 respectively), compared to southern Italy; women with a high educational level (OR(adj)=1.41; 95%CI: 1.02-1.93); and students (OR(adj)=1.64; 95%CI: 1.13-2.37). The low immunization rate highlights the difficulties of reaching young adult women, although the current coverage rates observed in the primary target population of HPV vaccination campaign (64%) emphasize that achieving high coverage rates is challenging also in younger age groups. Our results suggest that it would be premature to extend the active free-of-charge offer of HPV vaccination to older women and that efforts should be focused on the priority target, considering that the objective of 95% coverage established for this age group is still far from being attained., (Copyright © 2011 Elsevier Ltd. All rights reserved.)

Published
2011
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results